Sort
85,873 grants matching “alzheimers”
GaitIQ: Establishing a Digital Biomarker of Preclinical Alzheimer's Disease
$943,994Richard Morris · Gaitiq, Llc · R44 · FY2021 · AG
Sex-specific trajectories in epigenomic regulation of brain patterning
$943,862Flora M Vaccarino · Yale University · R01 · FY2024 · MH
Educating Physician-Neuroscientists: The R25 at UCSF
$943,772Stephen L Hauser · University Of California, San Francisco · R25 · FY2017 · NS
Beta Amyloid Deposits Imaged with 18F-AZD4694 and Postmortem Histology
$943,740Michael Tomblyn · Navidea Biopharmaceuticals, Inc. · R44 · FY2015 · AG
Environmental Exposure and DNA Damage
$943,608Jack A Taylor · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
$943,599Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2022 · AG
Dyadic Sleep, Biobehavioral Rhythms and Cognitive Function in Older Adults: Implications for Alzheimerâs Disease
$943,582Kelly Glazer Baron · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AG
Prospective Study of the Gut Microbiome in Aging
$943,516Andrew T Chan · Massachusetts General Hospital · R01 · FY2025 · AG
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$943,475Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2022 · AG
Design And Development Of Experimental Therapeutics
$943,412Nigel H. Greig · National Institute On Aging · Z01 · FY2008 · AG
Determinants of Individual Differences in the Efficacy of Aerobic Exercise to Improve Brain Health and Reduce Alzheimer Disease Risk in Older African Americans
$943,193Mark A Gluck · Rutgers The State Univ Of Nj Newark · R01 · FY2023 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2022 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2021 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2023 · AG
Project 1: Differential Roles of ApoE Isoforms in Neural Network Dysfunction of Alzheimer's Disease
$942,704Yadong Huang · J. David Gladstone Institutes · P01 · FY2024 · AG
Novel MRI Contrast Agent for Detection of Beta Amyloid
$942,582Peter Working · Alzeca Biosciences, Inc. · R44 · FY2017 · AG
ASSESSING EARLY ALZHEIMER AND AT-RISK GROUPS WITH PATIENT REPORTED OUTCOMES
$942,573Kathleen A Smyth · Case Western Reserve University · RC4 · FY2010 · AG
Imaging of Cognition, Learning and Memory in Aging
$942,326Yaakov Stern · Columbia University Health Sciences · R01 · FY2019 · AG
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia
$942,163Erez Eitan · Neurodex Inc · R44 · FY2024 · NS
The impact of bilingualism on cognitive reserve/resilience using socio-demographically and linguistically diverse populations
$942,151Boon Lead Tee · University Of California, San Francisco · R01 · FY2023 · AG
Preclinical discovery of novel farnesyltransferase inhibitors for the treatment of Alzheimer's disease and related tauopathies
$942,121Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
3D force sensing insoles for wearable, AI empowered, high-fidelity gait monitoring
$941,866Jonathan Daniel Miller · Axioforce Inc · R44 · FY2024 · EB
Epigenome Interactions in Complex Neurogenetic Disorders
$941,819Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · NS
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$941,795Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · AG
Develop AD Connectivity Maps with Human iPSC-Derived Brain Cells and their Use
$941,764Yadong Huang · J. David Gladstone Institutes · R01 · FY2024 · AG